drugset / Trial / NCT00186056

Mifepristone in Refractory Depression

NCT00186056

Completed 31 enrolled Stanford University
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the study is to examine the effectiveness of mifepristone treatment in patients with refractory depression. Refractory depression is defined as clinical depression that is unimproved after treatment with at least 2 different antidepressants of adequate dose and time trial. Mifepristone will augment current medications.

Timeline

Start
2003-01
Primary completion
2007-05
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Mifepristone Small molecule 300 mg Oral